Fig. 2
From: Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Summary of clinical courses of patients who developed malignancies during the primary study. Each bar represents one patient (patient number, age range in years); the length of the bar shows the length of time from benign diagnosis to malignant diagnosis. Patient numbers and age ranges (in brackets), instead of age at treatment, are identifiers for the purposes of this publication only and do not link to patients. GCTB giant cell tumor of bone, XRT, radiation therapy